Acutus Medical, Inc.
AFIB · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $20,157 | $7,164 | $3,031 | $17,263 |
| % Growth | 181.4% | 136.4% | -82.4% | – |
| Cost of Goods Sold | $19,144 | $10,301 | $31,910 | $32,925 |
| Gross Profit | $1,013 | -$3,137 | -$1,910 | -$15,662 |
| % Margin | 5% | -43.8% | -63% | -90.7% |
| R&D Expenses | $0 | $3,482 | $28,153 | $36,683 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $10,436 | $7,742 | $47,654 | $63,523 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$9,366 | $0 | -$54,745 | -$3,746 |
| Operating Expenses | $1,070 | $11,224 | $21,062 | $96,460 |
| Operating Income | -$57 | -$14,361 | -$22,972 | -$115,868 |
| % Margin | -0.3% | -200.5% | -757.9% | -671.2% |
| Other Income/Exp. Net | -$4,479 | $2,503 | $51,820 | -$1,815 |
| Pre-Tax Income | -$4,536 | -$11,858 | $28,848 | -$117,683 |
| Tax Expense | $0 | $63 | $15 | $0 |
| Net Income | -$9,547 | -$81,663 | -$39,616 | -$117,683 |
| % Margin | -47.4% | -1,139.9% | -1,307% | -681.7% |
| EPS | -0.32 | -2.81 | -1.39 | -4.11 |
| % Growth | 88.6% | -102.2% | 66.2% | – |
| EPS Diluted | -0.32 | -2.81 | -1.39 | -4.11 |
| Weighted Avg Shares Out | 29,768 | 29,095 | 28,471 | 28,654 |
| Weighted Avg Shares Out Dil | 29,768 | 29,095 | 28,471 | 28,654 |
| Supplemental Information | – | – | – | – |
| Interest Income | $763 | $2,588 | $868 | $116 |
| Interest Expense | $5,758 | $5,655 | $5,149 | $5,677 |
| Depreciation & Amortization | $1,027 | $874 | $1,208 | $6,890 |
| EBITDA | $2,249 | -$5,329 | $35,205 | -$105,116 |
| % Margin | 11.2% | -74.4% | 1,161.5% | -608.9% |